Current role
Biotechnology · Healthcare
Board Member
2026-06-25–present
Carole Nuechterlein, J.D.
Board Member
Aligos Therapeutics, Inc. (ALGS)Equibles does not estimate personal net worth.
Get an email with a short summary when Aligos Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ALGS alertsAbout Carole Nuechterlein, J.D.
Carole Nuechterlein, J.D. is recorded as Board Member at Aligos Therapeutics, Inc. (ALGS) since June 25, 2026. Aligos Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aligos Therapeutics, Inc. includes Lawrence M. Blatt (CEO and Board Member), Lesley Ann Calhoun (CFO and COO), Lucinda Y. Quan (General Counsel) and 7 others.
Affiliation history
-
Current
2026-06-25–present
Company network
Leadership on record at Aligos Therapeutics, Inc.
- Lawrence M. Blatt CEO, Board Member
- Lesley Ann Calhoun CFO, COO
- Lucinda Y. Quan General Counsel
- Nikhil Aneja Chief Accounting Officer
- Bridget Martell Board Member
- Bridget Martell, M.A., M.D. Board Member
- Bridget Martell, M.D. Board Member
- Carole Nuechterlein Board Member
- Heather Preston Board Member
- Heather Preston, M.D. Board Member
Recent activity
No call appearances or filed executive changes recorded yet.